Cargando…

Biotransformation of a potent anabolic steroid, mibolerone, with Cunninghamella blakesleeana, C. echinulata, and Macrophomina phaseolina, and biological activity evaluation of its metabolites

Seven metabolites were obtained from the microbial transformation of anabolic-androgenic steroid mibolerone (1) with Cunninghamella blakesleeana, C. echinulata, and Macrophomina phaseolina. Their structures were determined as 10β,17β-dihydroxy-7α,17α-dimethylestr-4-en-3-one (2), 6β,17β-dihydroxy-7α,...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddiqui, Mahwish, Ahmad, Malik Shoaib, Wahab, Atia-tul-, Yousuf, Sammer, Fatima, Narjis, Naveed Shaikh, Nimra, Rahman, Atta-ur-, Choudhary, M. Iqbal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325191/
https://www.ncbi.nlm.nih.gov/pubmed/28234904
http://dx.doi.org/10.1371/journal.pone.0171476
_version_ 1782510331678949376
author Siddiqui, Mahwish
Ahmad, Malik Shoaib
Wahab, Atia-tul-
Yousuf, Sammer
Fatima, Narjis
Naveed Shaikh, Nimra
Rahman, Atta-ur-
Choudhary, M. Iqbal
author_facet Siddiqui, Mahwish
Ahmad, Malik Shoaib
Wahab, Atia-tul-
Yousuf, Sammer
Fatima, Narjis
Naveed Shaikh, Nimra
Rahman, Atta-ur-
Choudhary, M. Iqbal
author_sort Siddiqui, Mahwish
collection PubMed
description Seven metabolites were obtained from the microbial transformation of anabolic-androgenic steroid mibolerone (1) with Cunninghamella blakesleeana, C. echinulata, and Macrophomina phaseolina. Their structures were determined as 10β,17β-dihydroxy-7α,17α-dimethylestr-4-en-3-one (2), 6β,17β-dihydroxy-7α,17α-dimethylestr-4-en-3-one (3), 6β,10β,17β-trihydroxy-7α,17α-dimethylestr-4-en-3-one (4), 11β,17β-dihydroxy-(20-hydroxymethyl)-7α,17α-dimethylestr-4-en-3-one (5), 1α,17β-dihydroxy-7α,17α-dimethylestr-4-en-3-one (6), 1α,11β,17β-trihydroxy-7α,17α-dimethylestr-4-en-3-one (7), and 11β,17β-dihydroxy-7α,17α-dimethylestr-4-en-3-one (8), on the basis of spectroscopic studies. All metabolites, except 8, were identified as new compounds. This study indicates that C. blakesleeana, and C. echinulata are able to catalyze hydroxylation at allylic positions, while M. phaseolina can catalyze hydroxylation of CH(2) and CH(3) groups of substrate 1. Mibolerone (1) was found to be a moderate inhibitor of β-glucuronidase enzyme (IC(50) = 42.98 ± 1.24 μM) during random biological screening, while its metabolites 2–4, and 8 were found to be inactive. Mibolerone (1) was also found to be significantly active against Leishmania major promastigotes (IC(50) = 29.64 ± 0.88 μM). Its transformed products 3 (IC(50) = 79.09 ± 0.06 μM), and 8 (IC(50) = 70.09 ± 0.05 μM) showed a weak leishmanicidal activity, while 2 and 4 were found to be inactive. In addition, substrate 1 (IC(50) = 35.7 ± 4.46 μM), and its metabolite 8 (IC(50) = 34.16 ± 5.3 μM) exhibited potent cytotoxicity against HeLa cancer cell line (human cervical carcinoma). Metabolite 2 (IC(50) = 46.5 ± 5.4 μM) also showed a significant cytotoxicity, while 3 (IC(50) = 107.8 ± 4.0 μM) and 4 (IC(50) = 152.5 ± 2.15 μM) showed weak cytotoxicity against HeLa cancer cell line. Compound 1 (IC(50) = 46.3 ± 11.7 μM), and its transformed products 2 (IC(50) = 43.3 ± 7.7 μM), 3 (IC(50) = 65.6 ± 2.5 μM), and 4 (IC(50) = 89.4 ± 2.7 μM) were also found to be moderately toxic to 3T3 cell line (mouse fibroblast). Interestingly, metabolite 8 showed no cytotoxicity against 3T3 cell line. Compounds 1–4, and 8 were also evaluated for inhibition of tyrosinase, carbonic anhydrase, and α-glucosidase enzymes, and all were found to be inactive.
format Online
Article
Text
id pubmed-5325191
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-53251912017-03-09 Biotransformation of a potent anabolic steroid, mibolerone, with Cunninghamella blakesleeana, C. echinulata, and Macrophomina phaseolina, and biological activity evaluation of its metabolites Siddiqui, Mahwish Ahmad, Malik Shoaib Wahab, Atia-tul- Yousuf, Sammer Fatima, Narjis Naveed Shaikh, Nimra Rahman, Atta-ur- Choudhary, M. Iqbal PLoS One Research Article Seven metabolites were obtained from the microbial transformation of anabolic-androgenic steroid mibolerone (1) with Cunninghamella blakesleeana, C. echinulata, and Macrophomina phaseolina. Their structures were determined as 10β,17β-dihydroxy-7α,17α-dimethylestr-4-en-3-one (2), 6β,17β-dihydroxy-7α,17α-dimethylestr-4-en-3-one (3), 6β,10β,17β-trihydroxy-7α,17α-dimethylestr-4-en-3-one (4), 11β,17β-dihydroxy-(20-hydroxymethyl)-7α,17α-dimethylestr-4-en-3-one (5), 1α,17β-dihydroxy-7α,17α-dimethylestr-4-en-3-one (6), 1α,11β,17β-trihydroxy-7α,17α-dimethylestr-4-en-3-one (7), and 11β,17β-dihydroxy-7α,17α-dimethylestr-4-en-3-one (8), on the basis of spectroscopic studies. All metabolites, except 8, were identified as new compounds. This study indicates that C. blakesleeana, and C. echinulata are able to catalyze hydroxylation at allylic positions, while M. phaseolina can catalyze hydroxylation of CH(2) and CH(3) groups of substrate 1. Mibolerone (1) was found to be a moderate inhibitor of β-glucuronidase enzyme (IC(50) = 42.98 ± 1.24 μM) during random biological screening, while its metabolites 2–4, and 8 were found to be inactive. Mibolerone (1) was also found to be significantly active against Leishmania major promastigotes (IC(50) = 29.64 ± 0.88 μM). Its transformed products 3 (IC(50) = 79.09 ± 0.06 μM), and 8 (IC(50) = 70.09 ± 0.05 μM) showed a weak leishmanicidal activity, while 2 and 4 were found to be inactive. In addition, substrate 1 (IC(50) = 35.7 ± 4.46 μM), and its metabolite 8 (IC(50) = 34.16 ± 5.3 μM) exhibited potent cytotoxicity against HeLa cancer cell line (human cervical carcinoma). Metabolite 2 (IC(50) = 46.5 ± 5.4 μM) also showed a significant cytotoxicity, while 3 (IC(50) = 107.8 ± 4.0 μM) and 4 (IC(50) = 152.5 ± 2.15 μM) showed weak cytotoxicity against HeLa cancer cell line. Compound 1 (IC(50) = 46.3 ± 11.7 μM), and its transformed products 2 (IC(50) = 43.3 ± 7.7 μM), 3 (IC(50) = 65.6 ± 2.5 μM), and 4 (IC(50) = 89.4 ± 2.7 μM) were also found to be moderately toxic to 3T3 cell line (mouse fibroblast). Interestingly, metabolite 8 showed no cytotoxicity against 3T3 cell line. Compounds 1–4, and 8 were also evaluated for inhibition of tyrosinase, carbonic anhydrase, and α-glucosidase enzymes, and all were found to be inactive. Public Library of Science 2017-02-24 /pmc/articles/PMC5325191/ /pubmed/28234904 http://dx.doi.org/10.1371/journal.pone.0171476 Text en © 2017 Siddiqui et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Siddiqui, Mahwish
Ahmad, Malik Shoaib
Wahab, Atia-tul-
Yousuf, Sammer
Fatima, Narjis
Naveed Shaikh, Nimra
Rahman, Atta-ur-
Choudhary, M. Iqbal
Biotransformation of a potent anabolic steroid, mibolerone, with Cunninghamella blakesleeana, C. echinulata, and Macrophomina phaseolina, and biological activity evaluation of its metabolites
title Biotransformation of a potent anabolic steroid, mibolerone, with Cunninghamella blakesleeana, C. echinulata, and Macrophomina phaseolina, and biological activity evaluation of its metabolites
title_full Biotransformation of a potent anabolic steroid, mibolerone, with Cunninghamella blakesleeana, C. echinulata, and Macrophomina phaseolina, and biological activity evaluation of its metabolites
title_fullStr Biotransformation of a potent anabolic steroid, mibolerone, with Cunninghamella blakesleeana, C. echinulata, and Macrophomina phaseolina, and biological activity evaluation of its metabolites
title_full_unstemmed Biotransformation of a potent anabolic steroid, mibolerone, with Cunninghamella blakesleeana, C. echinulata, and Macrophomina phaseolina, and biological activity evaluation of its metabolites
title_short Biotransformation of a potent anabolic steroid, mibolerone, with Cunninghamella blakesleeana, C. echinulata, and Macrophomina phaseolina, and biological activity evaluation of its metabolites
title_sort biotransformation of a potent anabolic steroid, mibolerone, with cunninghamella blakesleeana, c. echinulata, and macrophomina phaseolina, and biological activity evaluation of its metabolites
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325191/
https://www.ncbi.nlm.nih.gov/pubmed/28234904
http://dx.doi.org/10.1371/journal.pone.0171476
work_keys_str_mv AT siddiquimahwish biotransformationofapotentanabolicsteroidmiboleronewithcunninghamellablakesleeanacechinulataandmacrophominaphaseolinaandbiologicalactivityevaluationofitsmetabolites
AT ahmadmalikshoaib biotransformationofapotentanabolicsteroidmiboleronewithcunninghamellablakesleeanacechinulataandmacrophominaphaseolinaandbiologicalactivityevaluationofitsmetabolites
AT wahabatiatul biotransformationofapotentanabolicsteroidmiboleronewithcunninghamellablakesleeanacechinulataandmacrophominaphaseolinaandbiologicalactivityevaluationofitsmetabolites
AT yousufsammer biotransformationofapotentanabolicsteroidmiboleronewithcunninghamellablakesleeanacechinulataandmacrophominaphaseolinaandbiologicalactivityevaluationofitsmetabolites
AT fatimanarjis biotransformationofapotentanabolicsteroidmiboleronewithcunninghamellablakesleeanacechinulataandmacrophominaphaseolinaandbiologicalactivityevaluationofitsmetabolites
AT naveedshaikhnimra biotransformationofapotentanabolicsteroidmiboleronewithcunninghamellablakesleeanacechinulataandmacrophominaphaseolinaandbiologicalactivityevaluationofitsmetabolites
AT rahmanattaur biotransformationofapotentanabolicsteroidmiboleronewithcunninghamellablakesleeanacechinulataandmacrophominaphaseolinaandbiologicalactivityevaluationofitsmetabolites
AT choudharymiqbal biotransformationofapotentanabolicsteroidmiboleronewithcunninghamellablakesleeanacechinulataandmacrophominaphaseolinaandbiologicalactivityevaluationofitsmetabolites